Divi's Laboratories Ltd. (DIVI)

BSE


	Symbol		Exchange		Currency
	DIVI		NSE		INR	Real-time
	DIVI		Derived		INR	Real-time
	DIVIc1:NS		NSE		INR	Delayed
	DIVIc2:NS		NSE		INR	Delayed
	DIVI		BSE		INR	Delayed

Currency in INR

6,130.10

+34.10(+0.56%)

Closed06/12

Fair Value

Day's Range

6,104.75

6,183.05

52 wk Range

3,350.05

6,448.75

DIVI Income Statement

Featured here, the Income Statement (earnings report) for Divi's Laboratories Ltd., showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/03

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

53,944.7

69,694.7

89,599.2

77,670

78,450

Total Revenues Growth

+9.06%

+29.2%

+28.56%

-13.31%

+1%

Cost Of Revenues

22,455.5

24,718.2

31,604.7

32,740

33,520

Gross Profit

31,489.2

44,976.5

57,994.5

44,930

44,930

Gross Profit Growth

+4.19%

+42.83%

+28.94%

-22.53%

0%

Gross Profit Margin %

58.37%

64.53%

64.73%

57.85%

57.27%

Other Operating Expenses, Total

15,096.9

18,828.9

22,268.8

24,670

26,620

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+14.93%	+24.72%	+18.27%	+10.78%	+7.9%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6,316.8	8,366.9	9,570.9	9,870	11,060
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6,917.7	7,906.1	9,582.8	11,370	11,780

Operating Income

16,392.3

26,147.6

35,725.7

20,260

18,310

Operating Income Growth

-4.06%

+59.51%

+36.63%

-43.29%

-9.62%

EBIT Margin %

30.39%

37.52%

39.87%

26.08%

23.34%

Net Interest Expenses

384.9

568.5

685.9

2,050

2,980

Net Interest Expenses Growth

-56.96%

+47.7%

+20.65%

+198.88%

+45.37%

Interest Expense, Total

-55.4

-3.9

-3.7

-

-30

Interest And Investment Income

440.3

572.4

689.6

2,050

3,010

Other Non Operating Expenses, Total

856

-22.6

443.9

1,340

330

EBT, Excl. Unusual Items

17,633.2

26,693.5

36,855.5

23,650

21,620

Gain (Loss) On Sale Of Assets

-32.5

-59.6

-20.5

-10

-40

Other Unusual Items, Total

-

-

-

-

-

EBT, Incl. Unusual Items

18,194.6

26,660.4

36,835

23,690

21,630

EBT, Incl. Unusual Items Growth

-1.92%

+46.53%

+38.16%

-35.69%

-8.7%

EBT, Incl. Unusual Items Margin

33.73%

38.25%

41.11%

30.5%

27.57%

Income Tax Expense

4,429.2

6,817.5

7,230.5

5,450

5,630

Net Income to Company

13,765.4

19,842.9

29,604.5

18,240

16,000

Minority Interest

-

-

-

-

-

Net Income

13,765.4

19,842.9

29,604.5

18,240

16,000

Net Income Growth

+1.76%

+44.15%

+49.19%

-38.39%

-12.28%

Net Income Margin %

25.52%

28.47%

33.04%

23.48%

20.4%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

13,765.4

19,842.9

29,604.5

18,240

16,000

Basic EPS - Continuing Operations

51.85

74.75

111.52

68.71

60.27

Basic EPS - Continuing Operations Growth

+1.76%

+44.15%

+49.19%

-38.39%

-12.28%

Diluted EPS - Continuing Operations

51.85

74.75

111.52

68.69

60.27

Diluted EPS - Continuing Operations Growth

+1.75%

+44.16%

+49.19%

-38.4%

-12.26%

Basic Weighted Average Shares Outstanding

265.47

265.47

265.47

265.47

265.47

Diluted Weighted Average Shares Outstanding

265.47

265.47

265.47

265.47

265.47

Dividend Per Share

16

20

30

30

30

Dividend Per Share Growth

0%

+25%

+50%

0%

0%

EBITDA

18,224

28,665.5

38,800.8

23,640

22,050

EBITDA Growth

-2.8%

+57.3%

+35.36%

-39.07%

-6.73%

EBITDA Margin %

33.78%

41.13%

43.3%

30.44%

28.11%

EBIT